Our top pick for
Beginners

Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
Five9, Inc is a software-infrastructure business based in the US. Five9 shares (FIVN) are listed on the NASDAQ and all prices are listed in US Dollars. Five9 employs 1,210 staff and has a trailing 12-month revenue of around USD$434.9 million.
Our top pick for
Beginners
Our top pick for
Building a portfolio
Our top pick for
Advanced traders
52-week range | USD$52.51 - USD$194.035 |
---|---|
50-day moving average | USD$173.4727 |
200-day moving average | USD$149.3277 |
Wall St. target price | USD$198.41 |
PE ratio | N/A |
Dividend yield | N/A (0%) |
Earnings per share (TTM) | USD$-0.023 |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Valuing Five9 stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Five9's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Five9's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 15.4854. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Five9's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Five9's EBITDA (earnings before interest, taxes, depreciation and amortisation) is USD$13.4 million.
The EBITDA is a measure of a Five9's overall financial performance and is widely used to measure a its profitability.
Revenue TTM | USD$434.9 million |
---|---|
Gross profit TTM | USD$255.2 million |
Return on assets TTM | -0.95% |
Return on equity TTM | -17.72% |
Profit margin | -9.69% |
Book value | $4.221 |
Market capitalisation | USD$11.8 billion |
TTM: trailing 12 months
There are currently 2.9 million Five9 shares held short by investors – that's known as Five9's "short interest". This figure is 6.5% down from 3.2 million last month.
There are a few different ways that this level of interest in shorting Five9 shares can be evaluated.
Five9's "short interest ratio" (SIR) is the quantity of Five9 shares currently shorted divided by the average quantity of Five9 shares traded daily (recently around 659206.7114094). Five9's SIR currently stands at 4.47. In other words for every 100,000 Five9 shares traded daily on the market, roughly 4470 shares are currently held short.
However Five9's short interest can also be evaluated against the total number of Five9 shares, or, against the total number of tradable Five9 shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Five9's short interest could be expressed as 0.04% of the outstanding shares (for every 100,000 Five9 shares in existence, roughly 40 shares are currently held short) or 0.0504% of the tradable shares (for every 100,000 tradable Five9 shares, roughly 50 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Five9.
Find out more about how you can short Five9 stock.
We're not expecting Five9 to pay a dividend over the next 12 months.
Over the last 12 months, Five9's shares have ranged in value from as little as $52.51 up to $194.035. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Five9's is 0.4915. This would suggest that Five9's shares are less volatile than average (for this exchange).
Five9, Inc., together with its subsidiaries, provides cloud software for contact centers in the United States and internationally. The company offers virtual contact center cloud platform that delivers a suite of applications, which enables the breadth of contact center-related customer service, sales, and marketing functions; and acts as a hub for digital engagement channels between the clients and their customers, which enables them to manage the end-to-end customer experience in a single unified architecture. Its solution enables its clients to manage these customer interactions across various channels, including voice, chat, email, Web, social media, and mobile, as well as connects them to an appropriate agent. The company also provides a set of management applications, such as workforce management, reporting, quality management, and supervisor tools. It serves customers in various industries comprising banking and financial services, business process outsourcers, consumer, healthcare, and technology. Five9, Inc. has an alliance agreement with Deloitte Digital to bring transformational Cloud Contact Center as a Service (CCaaS) solutions to clients; and has strategic partnership with Conn3Ct Ltd. Five9, Inc. was founded in 2001 and is headquartered in San Ramon, California.
Everything we know about the Toast Inc IPO, plus information on how to buy in.
Everything we know about the Cyxtera IPO, plus information on how to buy in.
Everything we know about the ATI Physical Therapy IPO, plus information on how to buy in.
Everything we know about the Sportradar IPO, plus information on how to buy in.
Everything we know about the Longboard Pharmaceuticals Inc IPO, plus information on how to buy in.
Everything we know about the Prometheus Biosciences Inc IPO, plus information on how to buy in.
Everything we know about the Olo Inc IPO, plus information on how to buy in.
Everything we know about the China Eco-Materials Group Co Limited IPO, plus information on how to buy in.
Everything we know about the Gain Therapeutics Inc IPO, plus information on how to buy in.
Everything we know about the Karat Packaging Inc IPO, plus information on how to buy in.